Ester Alvino

1.1k total citations
35 papers, 813 citations indexed

About

Ester Alvino is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Ester Alvino has authored 35 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Pathology and Forensic Medicine and 9 papers in Cancer Research. Recurrent topics in Ester Alvino's work include Genetic factors in colorectal cancer (7 papers), Melanoma and MAPK Pathways (7 papers) and Cancer Genomics and Diagnostics (5 papers). Ester Alvino is often cited by papers focused on Genetic factors in colorectal cancer (7 papers), Melanoma and MAPK Pathways (7 papers) and Cancer Genomics and Diagnostics (5 papers). Ester Alvino collaborates with scholars based in Italy, Switzerland and United States. Ester Alvino's co-authors include Stefania D’Atri, Enzo Bonmassar, Lauretta Levati, Simona Caporali, Pedro Miguel Lacal, Nadia Felli, Alessandra Carè, Gian Carlo Antonini Cappellini, Giuseppe Starace and Daniele Castiglia and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Ester Alvino

35 papers receiving 803 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ester Alvino Italy 17 500 280 189 106 100 35 813
Jason R. Neil United States 11 564 1.1× 220 0.8× 366 1.9× 77 0.7× 84 0.8× 14 933
Brian P. Cook United States 11 562 1.1× 150 0.5× 258 1.4× 91 0.9× 118 1.2× 12 929
Katoh Japan 12 579 1.2× 179 0.6× 229 1.2× 112 1.1× 67 0.7× 17 841
Sébastien de Feraudy United States 13 277 0.6× 113 0.4× 174 0.9× 76 0.7× 96 1.0× 32 655
Xiaoling She China 23 695 1.4× 579 2.1× 152 0.8× 218 2.1× 246 2.5× 46 1.2k
Mari Kuraguchi United States 14 905 1.8× 259 0.9× 372 2.0× 72 0.7× 65 0.7× 17 1.3k
Alessandra Gentile Italy 16 618 1.2× 140 0.5× 316 1.7× 88 0.8× 139 1.4× 28 1.0k
Lorenza Pastorino Italy 21 734 1.5× 220 0.8× 525 2.8× 116 1.1× 49 0.5× 57 1.2k
Aude Mallavialle France 15 409 0.8× 161 0.6× 337 1.8× 184 1.7× 57 0.6× 23 791
Yoshinori Nimura Japan 19 824 1.6× 219 0.8× 713 3.8× 62 0.6× 133 1.3× 36 1.3k

Countries citing papers authored by Ester Alvino

Since Specialization
Citations

This map shows the geographic impact of Ester Alvino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Alvino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Alvino more than expected).

Fields of papers citing papers by Ester Alvino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ester Alvino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Alvino. The network helps show where Ester Alvino may publish in the future.

Co-authorship network of co-authors of Ester Alvino

This figure shows the co-authorship network connecting the top 25 collaborators of Ester Alvino. A scholar is included among the top collaborators of Ester Alvino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ester Alvino. Ester Alvino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Levati, Lauretta, Claudio Tabolacci, Antonio Facchiano, et al.. (2024). Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy. Journal of Experimental & Clinical Cancer Research. 43(1). 226–226. 3 indexed citations
2.
Levati, Lauretta, Cristian Bassi, Simona Mastroeni, et al.. (2022). Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with Targeted Therapy. Cancers. 14(15). 3706–3706. 7 indexed citations
3.
Caporali, Simona, Adriana Amaro, Lauretta Levati, et al.. (2019). miR-126-3p down-regulation contributes to dabrafenib acquired resistance in melanoma by up-regulating ADAM9 and VEGF-A. Journal of Experimental & Clinical Cancer Research. 38(1). 272–272. 69 indexed citations
4.
Caporali, Simona, Ester Alvino, Pedro Miguel Lacal, et al.. (2016). Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor. International Journal of Oncology. 49(3). 1164–1174. 56 indexed citations
5.
Caporali, Simona, Ester Alvino, Lauretta Levati, et al.. (2012). Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125. Biochemical Pharmacology. 84(5). 598–611. 24 indexed citations
6.
Levati, Lauretta, Elena Pagani, Sveva Romani, et al.. (2011). MicroRNA‐155 targets theSKIgene in human melanoma cell lines. Pigment Cell & Melanoma Research. 24(3). 538–550. 72 indexed citations
7.
8.
Castiglia, Daniele, Silvia Bernardini, Ester Alvino, et al.. (2008). Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma. Genes Chromosomes and Cancer. 47(7). 614–624. 26 indexed citations
9.
Caporali, Simona, Lauretta Levati, Giuseppe Starace, et al.. (2008). AKT Is Activated in an Ataxia-Telangiectasia and Rad3-Related-Dependent Manner in Response to Temozolomide and Confers Protection against Drug-Induced Cell Growth Inhibition. Molecular Pharmacology. 74(1). 173–183. 64 indexed citations
10.
Turriziani, Mario, Adriano Venditti, Francesco Marchesi, et al.. (2007). Novel role of triazenes in haematological malignancies: Pilot study of Temozolomide, Lomeguatrib and IL-2 in the chemo-immunotherapy of acute leukaemia. DNA repair. 6(8). 1179–1186. 16 indexed citations
11.
12.
Pallini, Roberto, Giulio Maira, Francesco Pierconti, et al.. (2003). Chordoma of the skull base: predictors of tumor recurrence. Journal of neurosurgery. 98(4). 812–822. 80 indexed citations
13.
Cimino-Reale, Graziella, Esterina Pascale, Ester Alvino, Giuseppe Starace, & Ettore D’Ambrosio. (2003). Long Telomeric C-rich 5′-Tails in Human Replicating Cells. Journal of Biological Chemistry. 278(4). 2136–2140. 26 indexed citations
14.
Pagani, Elena, Rita Pepponi, Maria Pia Fuggetta, et al.. (2003). DNA Repair Enzymes and Cytotoxic Effects of Temozolomide: Comparative Studies Between Tumor Cells and Normal Cells of the Immune System. Journal of Chemotherapy. 15(2). 173–183. 11 indexed citations
15.
Alvino, Ester, Eduardo Fernández, & Roberto Pallini. (2000). Microsatellite instability in primary brain tumors. Neurological Research. 22(6). 571–575. 11 indexed citations
16.
Alvino, Ester, et al.. (1997). In vitro antitumor activity of 3′-desamino-3′(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds. Cancer Chemotherapy and Pharmacology. 40(2). 180–184. 4 indexed citations
17.
D’Atri, Stefania, Ester Alvino, Maria Tricarico, et al.. (1992). Chemical xenogenization (CX) of cancer cells by triazene compounds: Studies with leukemia and melanoma cells. 2(3). 457–459. 1 indexed citations
18.
D’Onofrio, Chiara, et al.. (1990). Selection of HTLV-I positive clones is prevented by prostaglandin A in infected cord blood cultures. British Journal of Cancer. 61(2). 207–214. 23 indexed citations
19.
Alvino, Ester, et al.. (1988). Increase of Natural Killer Activity of Mouse Lymphocytes Followingin vitroandin VivoTreatment with Lithium. Immunopharmacology and Immunotoxicology. 10(1). 79–91. 9 indexed citations
20.
D’Onofrio, Chiara, et al.. (1987). Low concentrations of suramin can reduce in vitro infection of human cord blood lymphocytes with HTLV-I during long-term culture. Antiviral Research. 8(5-6). 247–260. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason R. Neil Breakdown of academic impact, for papers by Brian P. Cook Breakdown of academic impact, for papers by Katoh Breakdown of academic impact, for papers by Sébastien de Feraudy Breakdown of academic impact, for papers by Xiaoling She Breakdown of academic impact, for papers by Mari Kuraguchi Breakdown of academic impact, for papers by Alessandra Gentile Breakdown of academic impact, for papers by Lorenza Pastorino Breakdown of academic impact, for papers by Aude Mallavialle Breakdown of academic impact, for papers by Yoshinori Nimura
Rankless by CCL
2026